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Background: African animal trypanosomosis, transmitted cyclically by tsetse flies or mechanically by other biting
flies, causes serious inflictions to livestock health. This study investigates the extent of non-tsetse transmitted animal
trypanosomosis (NTTAT) by Trypanosoma (T.) evansi and T. vivax in domestic animals in the tsetse-free regions of
Northern Ethiopia, Afar and Tigray.
Methods: A cross sectional study was conducted on 754 dromedary camels, 493 cattle, 264 goats, 181 sheep,
84 donkeys, 25 horses and 10 mules. The microhaematocrit centrifugation technique was used as parasitological
test. Plasma was collected for serodiagnosis with CATT/T.evansi and RoTat 1.2 immune trypanolysis (ITL) while buffy
coat specimens were collected for molecular diagnosis with T. evansi type A specific RoTat 1.2 PCR, T. evansi type B
specific EVAB PCR and T. vivax specific TvPRAC PCR.
Results: The parasitological prevalence was 4.7% in Tigray and 2.7% in Afar and significantly higher (z = 2.53,
p = 0.011) in cattle (7.3%) than in the other hosts. Seroprevalence in CATT/T.evansi was 24.6% in Tigray and 13.9% in
Afar and was significantly higher (z = 9.39, p < 0.001) in cattle (37.3%) than in the other hosts. On the other hand,
seroprevalence assessed by ITL was only 1.9% suggesting cross reaction of CATT/T.evansi with T. vivax or other
trypanosome infections. Molecular prevalence of T. evansi type A was 8.0% in Tigray and in Afar and varied from
28.0% in horses to 2.2% in sheep. It was also significantly higher (p < 0.001) in camel (11.7%) than in cattle (6.1%),
donkey (6%), goat (3.8%), and sheep (2.2%). Four camels were positive for T. evansi type B. Molecular prevalence of
T. vivax was 3.0% and was similar in Tigray and Afar. It didn’t differ significantly among the host species except that
it was not detected in horses and mules.
Conclusions: NTTAT caused by T. vivax and T. evansi, is an important threat to animal health in Tigray and Afar. For
the first time, we confirm the presence of T. evansi type B in Ethiopian camels. Unexplained results obtained with
the current diagnostic tests in bovines warrant particular efforts to isolate and characterise trypanosome strains that
circulate in Northern Ethiopia.
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Ethiopia is the richest country in livestock population in
Africa with more than 52 million heads of cattle, 46
million small ruminants, about 9 million equines (don-
keys, horses and mules) and 1 million camels [1]. The live-
stock resource contributes to 12% of the total gross
domestic product (GDP) and over 45% of the agricultural
GDP of Ethiopia. However, the benefit derived from live-
stock is far below its potential. Inadequate food supply,
high disease prevalence, poor genetic resources and poor
marketing are the main bottlenecks for the development
of the livestock sector [2].
African trypanosomosis is one of the most important
animal diseases encountered in all agro-ecological zones
of the country and hinders the efforts made for food
self-sufficiency [3]. African trypanosomosis is a general
term for infections in many different hosts (man and his
domestic animals and wild animals) caused by various
trypanosome species with Trypanosoma (T.) brucei, T.
congolense, T. vivax, T. evansi and T. equiperdum as the
most important ones [4]. African animal trypanosomoses
(AAT) cause serious inflictions to the health of livestock
ranging from anaemia, loss of condition and emaciation,
abortion, death etc. [5-10]. The trypanosomes respon-
sible for AAT in Ethiopia are T. vivax, T. congolense,
T. brucei, T. evansi and T. equiperdum [11].
T. congolense and T. brucei are exclusively found in
the tsetse-infested areas of Ethiopia while T. evansi and
T. equiperdum occur in the tsetse-free areas. T. vivax
can be found in both tsetse-infested and tsetse-free areas
except in the highlands, which are >2500 meter above
sea level [11,12].
In Africa, T. vivax is transmitted both cyclically by
Glossina spp. and mechanically by horse flies (Tabanidae)
and stable flies (Stomoxys sp.). It circulates in several spe-
cies of ungulates including cattle, small ruminants, equids,
camelids and wild animals such as antelopes [4]. Wild
ungulates, especially buffaloes and antelopes, as well as
trypanotolerant cattle are generally symptomless carriers
[13]. T. vivax is also endemic in Latin America where its
transmission is exclusively mechanical through biting flies
[14-17].
T. evansi has multiple means of transmission of which
mechanical transmission by biting insects is the most im-
portant in camels and other large animals. Other trans-
mission routes such as the bite of vampire bats and oral
transmission in carnivores has been documented [4,18,19].
In Ethiopia, T. evansi is widely distributed across the
six agro-climatic zones and mainly coincides with the
distribution of camels [20]. Trypanosomosis due to T.
evansi (surra) is the number one protozoan disease of
camels. Horses are also very susceptible. Infected camels
and equines may die within 3 months. Moreover, cattle,
buffalo, pigs, goat and sheep infected with T. evansisuffer from immunosuppression, resulting in increased
susceptibility to other diseases or in vaccination failure
[21-23]. For example, experimental infections in buffalo
and pigs have shown reduced cellular and humoral re-
sponses after vaccination against classical swine fever
and Pasteurella multicoda in T. evansi infected animals
compared to uninfected animals [24-26].
T. evansi strains with kDNA minicircle type A are the
most abundant and found in Africa, South America and
Asia [27-29]. They are also characterised by the presence
of the gene for the Variant Surface Glycoprotein (VSG)
RoTat 1.2. This RoTat 1.2 VSG is expressed early during
infections resulting in the detectability of anti-RoTat 1.2
antibodies in animals infected with T. evansi type A [30].
In contrast, T. evansi strains with type B minicircle are
far less common and have so far been isolated only from
camels in Kenya [31-35]. Ngaira et al. showed that T.
evansi type B typically lacks the RoTat 1.2 gene and
as a consequence, infections with this type are not
detected with serological and molecular tests based
on RoTat 1.2 VSG, like CATT/T.evansi and RoTat 1.2
PCR [32,34,36,37].
Despite the considerable number of epidemiological
studies carried out in Ethiopia on cattle and camel trypa-
nosomosis in parts of Southern Nations, Nationalities,
and Peoples’ Region (SNNPR), and in Oromiya and
Amhara regions, information from Tigray and pastoral
areas of Afar, belonging to the tsetse-free areas of Ethiopia,
is scanty [38-45]. In addition, due to limited logistic resour-
ces and poor diagnostic facilities, the exact burden and
socioeconomic impact of AAT is probably underesti-
mated and information on prevailing trypanosome species
and affected hosts remains inaccurate and fragmented
[44,46,47]. Therefore, this study was designed to investi-
gate the distribution of T. evansi and T. vivax in selected
districts of Tigray and in pastoral areas of Afar.
Diagnosis of AAT is often based on clinical suspicion.
Parasite detection is cumbersome in many cases where
only low numbers of trypanosomes circulate in the host
body fluids [47]. Techniques for concentration of the
trypanosomes by centrifugation of a blood specimen can
be applied. After centrifugation of some blood in a capil-
lary tube, the trypanosomes can be detected directly
under the microscope at the level of the white blood cell
layer (the buffy coat) [48]. Where differential diagnosis is
needed, the capillary tube can be broken and the buffy
coat spread on a microscope slide for examination accord-
ing to Murray et al. [49]. A more sensitive technique is
the mini Anion Exchange Centrifugation Technique
(mAECT) but the technique works best with T. brucei and
T. evansi and has poor diagnostic potential for T. congo-
lense and T. vivax [50-53].
As an alternative to parasitological diagnosis, molecular
diagnostic tests have been developed. For the diagnosis of
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cific for T. evansi type A and PCR EVAB is specific for
T. evansi type B [34,37,54]. For the molecular diagnosis
of T. vivax, the ITS-1 PCR and proline racemase PCR
(TvPRAC PCR) can be employed [55,56]. Neither para-
sitological nor molecular tests are 100% sensitive, due to
the often low number of circulating parasites.
Serological tests are able to reveal ongoing or past
trypanosome infections based on antibody detection. For
surra, the most specific antibody detection tests make
use of the T. evansi specific variant surface glycoprotein
(VSG) RoTat 1.2 as antigen. The CATT/T.evansi is such
a test in the form of a direct agglutination test and is the
only rapid diagnostic test for surra that is recommended
by the World Organization for Animal Health [57,58].
By virtue of its format as a direct agglutination test,
CATT/T.evansi can be applied on any host species.
Knowledge about the antigenic repertoires of T. vivax
is almost non-existent. Most antibody detection tests
for T. vivax make use of more or less purified native
antigens leaving room for non-specific reactions. In
regions where T. vivax and T. brucei or T. evansi
occur together in the same host species, it is almost
impossible to identify the infecting trypanosome spe-
cies at the level of circulating antibodies in the host
[47,59-61]. Only recently, recombinant T. vivax specific
antigens are being investigated for their diagnostic
potential [62].Figure 1 Map of Ethiopia showing study districts in Tigray and Afar rThe present study provides data on the epidemiology
of AAT in domestic animals in two tsetse-free regions of
Ethiopia.
Methods
Study areas
The study was conducted in selected districts (weredas)
of Tigray and pastoral areas of Afar, representing tsetse-
free areas of Ethiopia. Tigray region is located in the
northern part of Ethiopia between longitudes 36°27′ E and
39°59′ E and latitudes 12°15′ N and 14°57′ N (Figure 1). It
shares international boundaries with Eritrea and Sudan
and regional boundaries with Amhara and Afar regions of
Ethiopia. Tigray is divided into four zones and 35 weredas
[63]. Selected “tabias” or peasant associations from the
districts of Raya-Azebo (southern zone), Tselemti (north-
western zone) and Kafta-Humera and Tsegede (western
zone), were included.
Afar region, one of the four major pastoral regions in
Ethiopia, occupies an area of about 270,000 km2 and is
situated between longitudes 39°34′E and 42°28′E and
latitudes 8°49′N and 14°30′N [64]. The region shares
international boundaries with the State of Eritrea and
Djibouti, as well as regional boundaries with the regions
of Tigray, Amhara, Oromia and Somali (Figure 1). The
Afar region consists of 5 administrative zones (sub-re-
gions) [65]. Taking into account the accessibility to the
pastoral communities, “kebeles” or sampling stations wereegions and tsetse belt areas.
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and Amibara (zone 3) and Gulina and Yalo (zone 4).
Ethics statement
The study protocol was approved by the Veterinary
Ethics Committee of the Institute of Tropical Medicine
(EXT2012-1).
Study design, study animals and specimen collection
Considering 95% confidence level and average preva-
lence of 30% [44], the number of specimens to collect
was planned according to Thrusfield [66] as n = (1.96)2 ×
Pexp(1-Pexp)/d
2; where: n = required sample size, d =
absolute precision required (d = 0.05), Pexp = expected
prevalence of the disease. A cross sectional study was
conducted from February till July 2013 on 1811 domes-
tic animals comprising 754 dromedary camels, 493 cat-
tle, 264 goats, 181 sheep, 84 donkeys, 25 horses and 10
mules. The animals were sampled at watering and graz-
ing points and at veterinary clinics where they were
brought for accaricide spraying and vaccination. Individ-
ual study subjects from willing owners were randomly
selected regardless of age, gender and body condition
[66]. From each animal, 9 mL of jugular vein blood was
collected in a heparinised Venosafe tube (Terumo,
Leuven, Belgium), labelled with a unique code, placed in
a coolbox at 4°C and processed as described below.
Packed cell volume (PCV) and microhaematocrit
centrifugation technique (mHCT)
The microhaematocrit (mHCT) was performed as de-
scribed by Woo [67]. Briefly, 4 microhaematocrit capil-
lary tubes were filled with approximately 50 μL of blood
from the Venosafe tube and stoppered with sealant.
After centrifugation at 12,000 rpm for 5 min, the PCV
was recorded and the tubes were mounted in a specially
designed viewing chamber and examined under the
microscope at 10x16 magnification for the presence of
motile trypanosomes at the level of the buffy coat as
described by Fikru et al. [44]. Animals with confirmed
presence of trypanosomes were treated free of charge
with 0.25 mg/kg melarsamine hydrochloride (cymelarsan)
in the case of camels or with 0.5 mg/kg isometamidium
chloride (samorin, trypamidium) or 7 mg/kg diminazenea-
ceturate (berenil) in the case of ruminants.
Preparation of plasma and buffy coat specimens
The blood collected in the heparinised Venosafe tubes was
centrifuged for 10 min at 1,000 rpm and plasma was col-
lected with a single use plastic transfer pipette into 2 mL
tubes with screwcaps (Sarstedt, Nümbrecht, Germany).
Plasma was stored at 4°C until testing for specific anti-
bodies with CATT/T.evansi and subsequently frozen
at −20°C. From the remaining blood specimen, 500 μL ofbuffy coat layer were collected by means of a micropipette
with a filter tip and mixed with an equal volume of guani-
dium EDTA buffer (GEB; 6 M guanidium chloride, 0.2 M
EDTA, pH 8.0) and stored at ambient temperature until
DNA extraction [68]. Of those animals that were parasito-
logically positive, part of the buffy coat was collected for
cryopreservation in liquid nitrogen for later isolation of
the parasite according to Pyana et al. [69].
CATT/T. evansi
Detection of T. evansi specific antibodies was carried
out by CATT/T.evansi on plasma that was prediluted
1:4 in CATT diluent, according to the instructions of the
manufacturer (Institute of Tropical Medicine, Antwerp,
Belgium).
Immune trypanolysis test for surra
From each plasma specimen, 30 μL were spotted on
Whatman 4 filter paper (Whatman, Maidstone, UK) in
Ethiopia and shipped to the Institute of Tropical Medi-
cine, Antwerp, Belgium. For elution of plasma and test
procedures, the protocol developed by Camara and co-
workers, with modifications, was employed [70]. Briefly,
from each filter paper, two 6 mm diameter disks were
punched and placed in a well of a flat bottom microlon
microtitre plate (Greiner Bio-One, Wemmel, Belgium).
Antibodies were eluted overnight at 4°C in 40 μL of fetal
bovine serum (FBS) followed by 1 hour on a plate shaker
at ambient temperature. Twenty μL of the eluted fraction
were transferred into a well of a U-bottom polystyrene
microtitre plate (Sterilin, Newport, UK). Next, T. evansi
RoTat 1.2 trypanosomes, grown in a mouse, were diluted
in ice-cold guinea pig serum (GPS) and kept on ice to ob-
tain a suspension of 5 trypanosomes per microscopic field
according to the matching method [71]. Twenty μL of this
suspension were added to each well of the microtiter plate
with the eluted specimens and incubated at ambient
temperature for 1 hour. Antibody mediated complement
lysis was assessed by dispensing 5 μL of the reaction mix-
ture on a microscope slide, covered by a 18×18 mm cover
slip and examination at 25×10 magnification under a
phase-contrast microscope. Trypanolysis was consid-
ered positive when at least 50% of the trypanosomes were
lysed [70].
DNA extraction
DNA extraction was performed with the High Pure PCR
Product Purification Kit (Roche Diagnostics, Mannheim,
Germany). Since unexpected clotting of the buffy coat
specimens preserved in GEB was observed, 200 μL of
tissue lysis buffer and 50 μL of proteinase K (Roche
Diagnostics, Mannheim, Germany) were added to the
1 mL buffy coat-GEB mixture followed by digestion for
90 min at 56°C under constant shaking at 1,000 rpm.
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ture and stored at −20°C until use. DNA concentrations
were measured in the Nanodrop ND-1000 UV–vis spec-
trophotometer (NanoDrop Technologies, Wilmington,
USA) or the Qubit 2.0 Fluorometer (Life Technologies,
Carlsbad, USA).
PCR
All PCR amplifications were carried out in 200 μL thin-
wall PCR tubes (ABgene, Epsom, UK) in a T3 ther-
mocycler 48 (Biometra, Göttingen, Germany). Amplified
products were visualised under UV after electrophoresis
in a 2% agarose gel at 135 V for 30 minutes and staining
with ethidium bromide. To check the quality of DNA, a
PCR targeting vertebrate cytochrome b was performed
[72,73]. To detect T. evansi type A, the RoTat 1.2 PCR
was conducted [37] while the EVAB PCR was used for
the detection of T. evansi type B [34]. Detection of T.
vivax was performed by means of TvPRAC PCR [56].
ITS1-PCR was used to test part of the specimen collec-
tion for T. congolense, T. theileri and Trypanozoon [55].
Each PCR assay was done in 25 μL reaction volumes
with 12.5 μL HotStarTaq polymerase master mix (Qiagen,
Leipzig, Germany) containing 2.5 units HotStarTaq DNA
polymerase, 1 × PCR buffer with 1.5 mM MgCl2 and
200 μM of each dNTP, 0.8 μM of each primer (Biolegio,
Amsterdam, Netherlands), 8 μL accugene water (Lonza,
Verviers, Belgium) and 2.5 μL of template DNA.
The target genes, primer names and sequences and
expected amplicon lengths are represented in Table 1.
Compared to the references cited in the table, some
minor changes were made at the level of the polymerase
and master mix, the initial denaturation step and the
numbers of cycles. Cycling conditions for the different
PCRs were as follows. Cytochrome B PCR: 94°C for
15 min and 35 cycles of 30 sec at 94°C, 30 sec at 52°C,
30 sec at 72°C and final extension for 5 min at 72°C.
RoTat 1.2 PCR: 94°C for 15 min and 40 cycles of 30 secTable 1 Specifications of the PCR assays used in the study
Taxon Target gene Primers Primer sequences
Vertebrates Cytochrome b L14841 5′-CCATCCAACATCT
H15149 5′-GCCCCTCAGAATG
T. evansi Type A VSG RoTat 1.2 RoTat1.2-F 5′-GCGGGGTGTTTAA
RoTat1.2-R 5′-ATTAGTGCTGCGT
T. evansi Type B minicircle EVAB-1 5′-ACAGTCCGAGAGA
EVAB-2 5′-CTGTACTCTACATC
T. vivax Proline racemase TvPRAC-F 5′ CGCAAGTGGACCG
TvPRAC-R 5′ ACGCGGGGCGAA
Diverse Trypanosoma
species
ITS-1 ITS-1 F 5′-TGTAGGTGAACCT
ITS-1 R 5′-CCAAGTCATCCAT
bp: base pairs.at 94°C, 30 sec at 59°C, 30 sec at 72°C and final exten-
sion for 5 min at 72°C. EVAB PCR: 94°C for 15 min and
30 cycles of 30 sec at 94°C, 30 sec at 60°C, 60 sec at 72°C
and final extension for 1 min at 72°C. TvPRAC PCR: 94°C
for 15 min and 30 cycles of 30 sec at 94°C, 30 sec at
63°C, 30 sec at 72°C and final extension for 5 min at
72°C. ITS-1 PCR: 94°C for 15 min and 40 cycles of
30 sec at 94°C, 30 sec at 60°C, 30 sec 72°C and final
extension for 5 min at 72°C.
Data analysis
All data were recorded in Microsoft Excel. STATA/MP
13.1 [74] was used for statistical analysis. Percentages
with 95% confidence interval (CI) were used to express
prevalence. Logistic regression was applied for asses-
sing differences in prevalence of AAT between domestic
animal species and evaluating the effect of infection (test
positive) on PCV values. To assess agreement between the
diagnostic tests, Cohen’s kappa coefficient was calcu-
lated and interpreted according to Landis and Koch [75].
P-values <0.05 were considered as significant.
Results
In total, 1811 animals were sampled of which 959 (53%)
in Tigray and 852 (47%) in Afar. In general, there was
statistically significant interaction (X2 = 330.12, p < 0.001)
between regions and sampled domestic animal species, i.e.
more cattle and camels were sampled in Tigray than in
Afar, while more sheep and goats were sampled in Afar
than in Tigray.
Parasite detection
In 68 animals, trypanosomes were detected (Table 2).
Thus, the overall parasitologically confirmed prevalence
of trypanosomosis was 3.8% (CI 2.9-4.6%) with 4.7%
(CI 3.4-6.0%) in Tigray and 2.7% (CI 1.6-3.8%) in Afar.
No trypanosomes were detected in equines. The parasi-
tological prevalence in cattle (7.3%, CI 5.0-9.5%) wasAmplicon length Reference
CAGCATGATGAAA-3′ 400 bp Adapted from [73]
ATATTTGTCCTCA-3′
AGCAATA-3′ 205 bp Adapted from [37]
GTGTTCG-3′
TAGAG-3′ 436 bp Adapted from [34]
TACCTC-3′
TTCGCCT- 3′ 239 bp Adapted from [56]
CAGAAGTG-3′
GCAGCTGGATC-3′ T. vivax 150 bp, T. theileri
350 bp, Trypanozoon 450 bp,
T. congolense 650 bp
[44]
CGCGACACGTT- 3′
Table 2 Test positives over total number of animals for each host species within each region
Diagnostic test Region Host species
Cattle Camel Goat Sheep Mule Horse Donkey
mHCT Tigray 32/411 11/343 1/60 1/64 0/10 0/25 0/46
Afar 4/82 19/411 0/204 0/117 - - 0/38
Total 36/493 30/754 1/264 1/181 0/10 0/25 0/84
CATT/T.evansi Tigray 169/411 39/343 12/60 14/64 0/10 0/25 2/46
Afar 15/82 64/411 23/204 9/117 - - 7/38
Total 184/493 103/754 35/264 23/181 0/10 0/25 9/84
ITL Tigray 0/411 21/343 1/60 1/64 0/10 0/25 0/46
Afar 0/82 9/411 1/204 0/117 - - 1/38
Total 0/493 30/754 2/264 1/181 0/10 0/25 1/84
RoTat 1.2 PCR Tigray 23/411 33/343 6/60 4/64 1/10 7/25 3/46
Afar 7/82 55/411 4/204 0/117 - - 2/38
Total 30/493 88/754 10/264 4/181 1/10 7/25 5/84
EVAB PCR Tigray 0/411 0/343 0/60 0/64 0/10 0/25 0/46
Afar 0/82 4/411 0/204 0/117 - - 0/38
Total 0/493 4/754 0/264 0/181 0/10 0/25 0/84
TvPRAC PCR Tigray 13/411 16/343 2/60 1/64 0/10 0/25 0/46
Afar 0/82 10/411 3/204 3/117 - - 3/38
Total 13/493 26/754 8/264 4/181 0/10 0/25 3/84
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(4.0%, CI 2.6-5.4%), sheep (0.6%, CI 0–1.7%) and goats
(0.4%, CI 0–1.2%).
Serology
With CATT/T.evansi, antibodies were detected in 354
animals (Table 2). Thus, the overall seroprevalence was
19.6% (CI 17.7-21.4%) with 24.6% (CI 21.9-27.3%) in
Tigray and 13.9% (CI 11.5-16.2%) in Afar. Among the
equines, CATT/T.evansi was only positive in donkeys
(10.7%, CI 4.0-17.4%). The overall seroprevalence was
significantly higher (z = 9.39, p < 0.001) in cattle (37.3%,
CI 33.1-41.6%) than in camels (13.7%, CI 11.2-16.1%), in
goats (13.3%, CI 9.2-17.4%), in sheep (12.7%, CI 7.8-17.6%)
and in donkeys (10.7%, CI 4.1-17.4%).
With the ITL (Table 2), T. evansi-specific antibodies
were detected only in 34 animals (30 camels, 2 goats, 1
sheep and 1 donkey). Thus, the seroprevalence in ITL
was 1.9% (34/1811, CI 1.3-2.5%).Table 3 Degree of agreement between diagnostic tests
Cross test Observed (%) Expec
CATT/T.evansi and ITL 81.45 79.31
CATT/T.evansi and RoTat 1.2 PCR 80.29 75.58
RoTat 1.2 PCR and ITL 92.10 90.42Kappa statistics indicated a poor but significant
agreement between CATT/T.evansi and ITL (p < 0.001,
Table 3).
Molecular diagnosis
The overall molecular prevalence of T. evansi type A
assessed with RoTat 1.2 PCR was 145/1811 or 8.0%
(CI 6.8-9.3%) with 8.0% (CI 6.3-9.8%) in Tigray and 8.0%
(CI 6.2-9.8%) in Afar (Table 2). The molecular prevalence
of T. evansi type A in camels (11.7%, CI 9.4-14.0%)
was significantly higher (p < 0.001) than in cattle (6.1%, CI
4.0-8.2%), donkeys (6.0%, CI 0.9-11.0%), goats (3.8%, CI
1.5-6.1%), and sheep (2.2%, 0.1-4.4%). The molecular
prevalence of T. evansi type A was 28.0% (CI 10.4-45.6%)
in horse and 10.0% (CI 7.6-27.6%) in mule. Kappa statis-
tics indicated a poor but significant agreement between
RoTat 1.2 PCR and the antibody detection tests, ITL
and CATT/T. evansi (p < 0.001, Table 3). Among the
145 RoTat 1.2 PCR positives, only 71 were positive inted by chance (%) Kappa Z p
0.10 8.45 <0.001
0.19 9.31 <0.001
0.176 9.75 <0.001
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Four camels, all from Awash Fentale district in Afar,
were found positive in EVAB PCR indicating the pres-
ence of T. evansi type B. All four were negative in
CATT/T.evansi and ITL although one of them was
also positive in RoTat 1.2 PCR suggesting a mixed
infection.
The overall molecular prevalence of T. vivax assessed
with TvPRAC PCR was 54/1811 or 3.0% (CI 2.2-3.8%)
with 3.3% (CI 2.2-4.5%) in Tigray and 2.6% (CI 1.5-3.7%)
in Afar (Table 2). The molecular prevalences of T. vivax
were 3.5% (CI 2.2-4.8%) in camels, 3.0% in goats (CI 1.0-
5.1%), 2.6% (CI 1.2-4.1%) in cattle and 2.2% (CI 0.1-4.4%)
in sheep and were not significantly different (p = 0.925).
All horses and mules were negative in TvPRAC PCR. The
molecular prevalence of T. vivax in cattle from Tigray was
3.2% (13/411) but was 0% in Afar. Among the 54 TvPRAC
PCR positives, 10 were also positive in CATT/T.evansi
but were negative in RoTat 1.2 PCR. Only two camels and
one goat were positive in both TvPRAC PCR and RoTat
1.2 PCR.
Among the 68 parasitologically positive animals, 32
cattle, 1 camel and 1 sheep were negative in the RoTat
1.2 PCR, EVAB PCR and TvPRAC PCR. To check
for the possibility that mHCT detected T. theileri and
T. congolense, ITS1-PCR was run on their specimens.
Four cattle were positive for T. vivax and two cattle spe-
cimens were positive for T. theileri. Ten were negative.Table 4 Average PCV of the animals according to their status
Test Species % PCV non-infected ± SDa % PCV in
mHCT Camels 25.8 ± 3.53 21.5 ± 2.53
Cattle 25.9 ± 5.25 24.9 ± 5.49
CATT/T.evansi Camels 25.9 ± 3.46 23.8 ± 3.87
Cattle 26.6 ± 5.69 24.6 ± 4.19
Equines 33.6 ± 6.3 27.9 ± 7.9
Goats 26.7 ± 5.84 24.9 ± 4.57
Sheep 25.1 ± 5.57 22.9 ± 6.11
RoTat 1.2 PCR Camels 25.0 ± 3.49 23.7 ± 3.81
Cattle 25.8 ± 5.25 26.3 ± 5.56
Equines 33.2 ± 6.6 33.1 ± 7.1
Goats 26.5 ± 5.68 23.3 ± 5.89
Sheep 24.8 ± 5.71 25.5 ± 3.89
TvPRAC Camels 25.7 ± 3.57 23.8 ± 3.77
Cattle 25.9 ± 5.30 23.1 ± 2.91
Equines 33.2 ± 6.6 33.2 ± 5
Goats 26.4 ± 5.71 26.9 ± 6.30
Sheep 24.8 ± 5.70 23.8 ± 4.33
aSD: standard deviation.
bt: Student’s t distribution value.
cP: probability.
*Statistically significant reduction in PCV.No single one was positive for T. congolense. Eighteen
cattle specimens showed a profile with amplicons of dif-
ferent lengths that could not be interpreted unequivocally.
Among the CATT/T.evansi positive animals, 269 (77%)
were negative in all PCR tests (165 cattle, 42 camels, 33
goats, 22 sheep and 7 donkeys).
Packed cell volume (PCV)
In Table 4, the average PCV values and standard devia-
tions (SD) are given according to the status of the ani-
mals in the mHCT, CATT/T. evansi, RoTat 1.2 PCR and
TvPRAC PCR. Camels that were found positive in those
tests had a significantly lower average PCV than the ani-
mals that were negative in the different tests. The aver-
age PCV in ITL positive camels (24.2% ± 3.4%) was not
significantly different from ITL negatives (25.7% ± 3.59%)
(p = 0.05). In cattle and equines, the average PCV value
was significantly lower only in CATT/T.evansi positive
animals. In sheep and goats, no significant differences in
average PCV were observed.
Discussion
In this cross sectional study, the mHCT, CATT/T.evansi,
RoTat 1.2 ITL and RoTat 1.2 PCR, EVAB PCR and
TvPRAC PCR were used to assess the non-tsetse trans-
mitted AAT prevalence in domestic animals in two re-
gions of northern Ethiopia, Tigray and Afar. The overall
prevalence of AAT as assessed with mHCT was 3.75%in the different diagnostic tests
fected ± SDa Regression coefficient value tb Pc
−4.23 −6.50 <0.001*
−0.97 −1.07 0.287
−2.09 −5.59 <0.001*
−2.02 −4.20 <0.001*
−5.71 −2.56 0.012*
−1.79 −1.73 0.084
−2.12 −1.77 0.088
−2.16 −5.39 <0.001*
0.53 0.54 0.591
−0.98 −0.05 0.960
−3.29 −1.79 0.074
0.74 0.26 0.796
−1.89 −2.65 0.008*
−2.83 −1.92 0.056
−0.003 0.00 0.999
0.543 0.26 0.792
−1.05 −0.36 0.716
Birhanu et al. Parasites & Vectors  (2015) 8:212 Page 8 of 11which was similar to AAT prevalence reported in cattle
from other tsetse-free areas in Ethiopia (3.2% in Gondar
and Bale Lowlands) using the same technique [44]. This
is probably underestimating the real prevalence since
mHCT is acknowledged to detect <50% of infections
with low parasitaemia [49,76]. Although only one goat
and one sheep were positive in mHCT, this finding con-
firms the presence of trypanosomosis in small ruminants
[38,77-79]. The fact that no single equine was positive in
mHCT while some of them were positive in the T.
evansi specific RoTat 1.2 PCR and the T. vivax specific
TvPRAC PCR, indicates that in these animals the para-
sitaemia level remained under the lower detection limit
of mHCT (about 60 trypanosomes/mL, [80].
With RoTat 1.2 PCR, it was confirmed that all domes-
tic animals are susceptible to infection with T. evansi
type A but that camels and horses are particularly at risk
[21,22]. With EVAB PCR, we report for the first time
the presence of T. evansi type B in camel in Ethiopia.
Till today, T. evansi type B has only been isolated from
camel in Kenya although indirect evidence exists that it
also circulates in Sudan [31,32,81,82]. Furthermore,
Hagos et al. suggested the existence of non-RoTat 1.2
T. evansi in camels from Bale zone in Ethiopia based
on their finding that about one third of parasitologic-
ally positive camels were negative in CATT/T.evansi
[45]. Also in our study, all four camels with T. evansi
type B were negative in CATT/T. evansi. These data
suggest that T. evansi type B is not confined to Kenya
but may occur in more East African countries and even
beyond, thus calling for the adaptation of serological and
molecular diagnostic tests, like CATT/T.evansi and RoTat
1.2 PCR, to ensure detection of both types of T. evansi
without compromising specificity.
Our study also confirms that T. vivax can infect
diverse domestic animal species, including donkeys [4].
The overall molecular prevalence of T. vivax as assessed
with TvPRAC PCR was lower than reported in other
studies [44,56]. The present study shows that camels in
Ethiopia can be infected with T. vivax and that infection
is associated with morbidity reflected by a significant
reduction in PCV. Co-infections withT. vivax and T. evansi
were rare (2 camels, 1 goat) but characterised by low
PCV (20–22.5%). Mixed infection by both parasites was
also reported in [83].
As expected, ITS1 PCR confirmed the absence of
T. congolense in the mHCT positive animals that were
negative in RoTat 1.2 PCR and TvPRAC PCR but revealed
four T. vivax infections that were not picked up by
TvPRAC PCR. Interestingly, ten mHCT positive animals
remained negative in all PCRs. In the single sheep, the
presence of the non-pathogenic T. melophagium cannot
be ruled out but the other nine negatives remain unex-
plained [84,85]. Also unexplained remain the 18 cattlespecimens showing a complex amplicon profile in ITS1
PCR, including a putative T. vivax specific 150 bp ampli-
con. In a previous study, which led to the development of
the TvPRAC PCR, we observed that the ITS1 PCR can
generate non-specific amplicons in the presence of cattle
DNA rendering unequivocal interpretation of the results
impossible [44]. Although the analytical sensitivity of
TvPRAC is lower than of ITS1 PCR, it is still much
higher than of mHCT [56]. Therefore, mHCT positive
and TvPRAC negative but ITS1 T. vivax positive speci-
mens may be due to particular T. vivax strains not detect-
able in TvPRAC. To further investigate these unexplained
results, it will be necessary to isolate the trypanosomes de-
tected in the mHCT, which will be particularly challenging
in case of T. vivax. Indeed, T. vivax is notoriously difficult
to grow in laboratory rodents and/or in culture [86,87].
Seroprevalence, as assessed with CATT/T.evansi was
much higher than molecular prevalence which is not
unexpected for several reasons. First, CATT/T.evansi
cannot distinguish current from cured infection as detect-
able level of antibodies can persist for 2.3–22.6 month
after trypanocidal treatment [88,89]. Secondly, in particu-
lar in chronic infections, parasitaemia can be well below
the detection limit of parasitological and even molecular
diagnostic tests, a phenomenon well known in human
African trypanosomosis but less studied in AAT [90,91].
Finally, as CATT/T.evansi is not 100% specific, false posi-
tive cases do occur [92].
Still, the poor agreement between CATT/T.evansi and
ITL is puzzling. Both serological tests detect antibodies
against the VSG RoTat 1.2 that is considered specific for
T. evansi type A. Although a limited loss in sensitivity of
ITL when performed on filter paper eluates may be ex-
pected other factors may cause this discrepancy [70,93].
While ITL detects exclusively variant specific antibodies,
CATT/T.evansi detects also antibodies directed against
non-variant specific epitopes of VSG RoTAt 1.2 and
other surface exposed antigens. Thus, infection with
other trypanosomes, e.g. T. vivax, may lead to a positive
result in CATT/T.evansi as was suggested in a study on
bovine trypanosomosis in Suriname [47,60,94]. This cross-
reactivity caused by T. vivax infection may explain why all
CATT/T.evansi positive cattle specimens remained nega-
tive in ITL. However, it provides no explanation why the 30
cattle specimens that were positive in RoTat 1.2 PCR
remained negative in ITL and why from the 145 RoTat 1.2
PCR positives, only 71 were also positive in CATT/T.
evansi. Is it possible that the target sequence of RoTat 1.2
PCR is also present in some particular T. vivax strains cir-
culating in Afar and Tigray but that the gene containing
that sequence is a pseudogene or a gene that is not
expressed during an infection? As we were not able to iso-
late T. vivax strains during this study, a conclusive answer
to this question cannot be given.
Birhanu et al. Parasites & Vectors  (2015) 8:212 Page 9 of 11If one considers a low PCV as a morbidity marker, it is
striking that mainly camels are susceptible to AAT as
disease. Indeed, camels that were positive in mHCT,
CATT/T.evansi, RoTat 1.2 PCR and TvPRAC PCR had a
significantly lower PCV than camels that were negative
in all these tests. Among the other host species, only cat-
tle and equines that were positive in CATT/T.evansi had
a significantly lower PCV than CATT/T.evansi negative
animals again suggesting that most CATT/T.evansi
positive animals were actually infected, whether with
T. evansi or T. vivax.
Among the parasitologically positive animals, three
quarter presented without or with only mild symptoms.
As in the study region, it is common to treat only sick
camels and bovines with trypanocidal drugs such as
diminazine and isometamidum, asymptomatic infections
remain without treatment and constitute an uncontrolled
reservoir for the disease.
Our study has some limitations. Although intended, it
was not possible to compare the AAT prevalence be-
tween Tigray and Afar since the number of examined
individuals per animal species was considerably different
between two study regions. Also, no stained blood prep-
arations were prepared that would have allowed mor-
phological characterisation of those parasites that were
detected in the mHCT but that remained negative in the
species-specific PCRs.
Conclusions
This study shows that non-tsetse transmitted AAT is an
important threat to the health of camels, equine and
ruminants in Afar and Tigray regions in Ethiopia. In
these regions, AAT is caused by T. vivax and T. evansi
type A and type B, the latter only in camels. Hence,
improving serological and molecular diagnostic tests to
detect both types of T. evansi as well as T. vivax is ne-
cessary. Unexplained results obtained with the current
diagnostic tests in bovine specimens warrant particular
efforts to isolate and characterise trypanosome strains
that circulate in Northern Ethiopia.
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